换一批
换一批[The use of targeted therapies in oncology and their impact in the design of clinical trials: epidermal growth factor receptors 1 and 2 as a paradigm].
作者：
主题词
抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤药(Antineoplastic Agents);乳腺肿瘤(Breast Neoplasms);临床试验(主题)(Clinical Trials as Topic);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);人类(Humans);医学肿瘤学(Medical Oncology);分子靶向治疗(Molecular Targeted Therapy);肿瘤蛋白质类(Neoplasm Proteins);肿瘤(Neoplasms);蛋白激酶抑制剂(Protein Kinase Inhibitors);喹唑啉类(Quinazolines);研究设计(Research Design);信号传导(Signal Transduction)
DOI
10.1016/j.medcli.2013.04.008
PMID
23809407
发布时间
2021-12-03
- 浏览10
Medicina clinica
176-80页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
